Maxim Group Downgrades Cancer Genetics, Inc. (CGIX) to Hold
Tweet Send to a Friend
Maxim Group downgraded Cancer Genetics, Inc. (NASDAQ: CGIX) from Buy to Hold.Analyst Jason McCarthy commented, "We are downgrading CGIX to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
